EN DE
Watch SS Innovations International Inc. Common Stock for free: we tell you when fair value or trend changes.
Data-driven stock valuation

SS Innovations International Inc. (SSII) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of SS Innovations International Inc. stock $1.36, price $1.61, that is 15.5% below the price, quality 41 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Based in India

SI SS Innovations International Inc. logo Thin data Nov 10, 2026

SS Innovations International Inc.

SSII · US
Expensive, weak quality

Our calculation puts a fair price 16% below what the stock costs today.

Low debt
Revenue last quarter +39% vs. a year ago.
Quality 41/100
Mixed Growth (revenue 3y +207.7 %/yr in USD)
Insiders sold $99,999 (6M)
Fair value $1.36 · Overvalued
Loss-making · -23.7% net margin (TTM)
Negative free cash flow
Trails peers (2/10)
Narrow moat 8/100 · thin data
Thin data
Estimate⚠ Small free float
Watch SS Innovations International Inc. Common Stock for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$16.25 $0.0010 Fair Value $1.36 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0010 – $16.25 · fair‑value band $1.02 – $1.70 · the $1.61 price screens above the $1.36 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow SS Innovations International Inc. Common Stock in your weekly email

Every Wednesday you see whether SS Innovations International Inc. Common Stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.

Show moreShow less

It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.

The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa " Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device.

In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products.

Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

Stock analysis

SS Innovations International Inc. (SSII) currently trades at $1.61, while our estimate is $1.36, 16% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $1.02 (bear) to $1.70 (bull), the price of $1.61 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

SS Innovations International Inc. Common Stock reported revenue of $42.5M in FY2025 versus $0 in FY2021. Reported net income was −$12.1M in FY2025.

Key figures

Market cap $331M Small · P/S ratio 9.33 · EPS (TTM) $−0.0600 · Net margin −23.7% · Return on equity −26.1% · Return on assets (EBIT) −109% (5-year average) · Operating margin −16.3% · Revenue (TTM) $52.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 77% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 8% fair-value upside, at −16%, SSII screens richer than that median.

Fair Value

Bear $1.02 Fair Value $1.36 Bull $1.70
Price $1.61 · Downside -15.5%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 41/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 17
How much profit the company makes from its sales and capital
Quality Growth 99
Are margins and returns getting better?
Cashflow 23
Do the profits arrive as real cash?
Financial strength 69
Debt, balance sheet and risk of trouble
Investment 32
Does it invest with discipline instead of growing at any price?
Low Volatility 41
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 13
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $99,999 and none bought.

  • SaleSrivastava SudhirChairman and CEO, Director, 10% owner33,333 shares at $3.00$99,999Sep 4, 2026
  • BuySrivastava SudhirChairman and CEO, Director, 10% owner498,753 shares at $4.01$2.0MMar 6, 2026
  • BuyTimothy P. AdamsDirector300,000 shares at $3.99$1.2MMar 6, 2026
  • BuyFrederic H MollDirector, 10% owner501,253 shares at $3.99$2.0MMar 6, 2026

Plus 6 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 10, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+105.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+207.7%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−389.4% (2022) → −19.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

SSII screens overvalued: fair value 16% below the price. Compare with Abbott Laboratories, →

Compare SS Innovations International Inc. Common Stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 402 stocks

Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Below median
Fair Value upside −15.5% · Below median
Profitability
Return on assets −16.3% · Below median
Net margin (12 months) −23.7% · Below median
Operating margin (12 months) −16.3% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 39.4% · Top 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 8.66× · Priciest 25%
P/S (12 months) 6.32× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)13 · sector 17
FUTURE (revenue growth)100 · sector 44
PAST (return on equity)0 · sector 0
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥178.92 ¥202.57 +13% vs SSII
DexCom, Inc DXCM $79.92 $89.18 +12% vs SSII
Stryker Corporation SYK $324.29 $358.30 +10% vs SSII
STERIS plc STE $257.12 $279.53 +9% vs SSII
Boston Scientific Corporation BSX $44.70 $48.42 +8% vs SSII
GE HealthCare Technologies Inc GEHC $83.65 $69.92 −16% vs SSII
Edwards Lifesciences Corporation EW $104.01 $81.94 −21% vs SSII
Abbott Laboratories, ABT $110.46 $75.28 −32% vs SSII
Medtronic plc MDT $101.59 $65.61 −35% vs SSII
Koninklijke Philips N.V PHIA €27.06 €15.23 −44% vs SSII

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

SS Innovations International Inc. Common Stock: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "SS Innovations International Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/SSII

Frequently asked questions

Is SS Innovations International Inc. (SSII) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $1.36 versus a price of $1.61, about 16% lower (overvalued).
What is the fair value of SSII?
Our estimate for SS Innovations International Inc. is $1.36 (as of Nov 10, 2026), built from audited fundamentals. The current price: $1.61.
What is the quality score of SSII?
SS Innovations International Inc. has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SS Innovations International Inc. (SSII)?
Our calculated price target is the estimate of $1.36 (as of Nov 10, 2026). Cautious scenario $1.02, optimistic scenario $1.70. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the SS Innovations International Inc. Common Stock stock forecast for 2026?
Our estimate puts fair value at $1.36, about 16% lower versus a price of $1.61 (overvalued). Cautious scenario $1.02, optimistic scenario $1.70. The calculation is refreshed regularly with new filings.
What is the revenue of SS Innovations International Inc. (SSII)?
SS Innovations International Inc. reported trailing-twelve-month revenue of about $52.4M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of SS Innovations International Inc. (SSII)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SS Innovations International Inc. it is $1.36 per share (as of Nov 10, 2026), against a price of $1.61.
Is SS Innovations International Inc. Common Stock stock overvalued or undervalued in 2026?
As of Nov 10, 2026, SSII trades above its calculated fair value: price $1.61, fair value $1.36, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SSII?
No. The price is what the market pays today ($1.61); the fair value is what the company's own numbers justify ($1.36). For SS Innovations International Inc. the two are $0.2500 per share apart. That gap is exactly why we show both numbers side by side.
How much is SS Innovations International Inc. Common Stock worth?
The market values SS Innovations International Inc. at about $331M (market capitalisation, as of Nov 10, 2026). Per share that is $1.61; our models calculate a fair value of $1.36 per share.
What do the bullish and bearish scenarios say about SSII?
Our models span a range for SS Innovations International Inc.: cautious scenario $1.02, base $1.36, optimistic $1.70 per share (as of Nov 10, 2026, price $1.61). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SS Innovations International Inc. (SSII)?
Balance-sheet figures for SS Innovations International Inc. (as of Nov 10, 2026): return on equity −26.1%, debt of 0.01 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is SSII from its 52-week high?
SS Innovations International Inc. trades at $1.61, about 77% below its 52-week high of $7.00 and at the low of $1.61 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of $1.36 is for.
Which stocks are comparable to SS Innovations International Inc. Common Stock?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SS Innovations International Inc. Common Stock stock attractive at the current price?
The data as of Nov 10, 2026: price $1.61, calculated fair value $1.36 (−16%), Quality Score 41/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. SS Innovations International Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SS Innovations International Inc. (SSII)?
The closing price on Nov 10, 2026 was $1.61. Our estimate is $1.36, about 16% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SS Innovations International Inc. Common Stock right now?
Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of SS Innovations International Inc.

How large is the market capitalisation of SS Innovations International Inc. (SSII)?
The market capitalisation of SS Innovations International Inc. is $331M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SS Innovations International Inc. (SSII)?
The price-to-sales ratio of SS Innovations International Inc. is 9.33 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of SS Innovations International Inc. (SSII)?
Earnings per share at SS Innovations International Inc. are $−0.0600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of SS Innovations International Inc. (SSII)?
The net margin of SS Innovations International Inc. is −23.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SS Innovations International Inc. (SSII)?
The return on equity (ROE) of SS Innovations International Inc. is −26.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SS Innovations International Inc. (SSII)?
On an EBIT basis the return on assets of SS Innovations International Inc. is −109% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SS Innovations International Inc. (SSII)?
The operating margin of SS Innovations International Inc. is −16.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SS Innovations International Inc. (SSII)?
Revenue at SS Innovations International Inc. is growing +39.4% versus a year earlier (3y avg +208%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does SS Innovations International Inc. (SSII) generate?
The free cash flow of SS Innovations International Inc. is −$22.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does SS Innovations International Inc. (SSII) carry?
The net debt of SS Innovations International Inc. is $11.2M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch SS Innovations International Inc. Common Stock in the live analysis

One click puts SS Innovations International Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.